武汉佰乐博生物技术有限公司
   
     
联系热线
  • 联系人:方经理
  • 电 话:027-65279366
  • 邮箱:products@biolabreagent.com
  • 地 址:武汉市东湖新技术开发区神墩四路666号C栋

Anti-HRSV-A/B G/Major surface glycoprotein G Antibody (131-2G),AntibodySystem Laboratories

发表时间:2023-06-14

标题:Anti-HRSV-A/B G/Major surface glycoprotein G Antibody (131-2G),AntibodySystem Laboratories

货号:RVV08503

产品链接:http://www.antibodysystem.com/product/7055.html

寄主物种:Human

形式:Liquid

存储缓冲区:0.01M PBS, pH 7.4.

物种反应性:Human respiratory syncytial virus A/B

纯度:>95% by SDS-PAGE.

应用:ELISA,IF

储存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

免费热线:027-65279366 /18108604356
QQ:2663991332
咨询邮箱:products@biolabreagent.com
选购商城:https://www.antibodysystem.com
微信公众平台:佰乐博生物Biolab Reagents

参考文献:

Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. PMID: 24990999

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. PMID: 25965801

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model. PMID: 29678551

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice. PMID: 23300550

Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease. PMID: 26473935

A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. PMID: 23885067

Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice. PMID: 20592094

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. PMID: 19545210

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice. PMID: 19264600

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. PMID: 28275196

联系方式
手机:18108604356
微信扫一扫